Showing results (1121-1130 of 1,484) with videos related to

Sort By:
Pageof 149
Stem Cells and Development|January 14, 2015
Therapeutic potential of gingival fibroblasts for cutaneous radiation syndrome: comparison to bone marrow-mesenchymal stem cell graftsChristine Linard, Frederique Tissedre, Elodie Busson, et al.
American Journal of Veterinary Research|December 30, 2017
Comparative pharmacokinetics of two florfenicol formulations following intramuscular and subcutaneous administration to sheepChristie C Balcomb, John A Angelos, Munashe Chigerwe, et al.
Macromolecular Bioscience|June 4, 2015
Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer's DiseaseRameshwar Patil, Pallavi R Gangalum, Shawn Wagner, et al.
Journal of Ethnopharmacology|September 24, 2011
Antimicrobial evaluation of Huilliche plant medicine used to treat woundsPer Mølgaard, Jes Gitz Holler, Betül Asar, et al.
Urology|September 2, 2022
Urology Consult: Association with Renal Trauma Imaging and InterventionShirley L Wang, Pranjal Agrawal, Mary Rostom, et al.
Transplantation and Cellular Therapy|September 30, 2023
Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center AnalysisJana Doering, Markus Perl, Daniela Weber, et al.
Blood|July 26, 2015
Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcomeDaniela Weber, Peter J Oefner, Andreas Hiergeist, et al.
Acta Neuropathologica Communications|October 8, 2020
Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutationsMeixiang Huang, Erica Modeste, Eric Dammer, et al.
Journal of Materials Chemistry. B|April 9, 2020
Construction of giant glycosidase inhibitors from iminosugar-substituted fullerene macromonomersThi Minh Nguyet Trinh, Michel Holler, Jérémy P Schneider, et al.
Plos Neglected Tropical Diseases|April 13, 2011
Trypanosoma brucei glycogen synthase kinase-3, a target for anti-trypanosomal drug development: a public-private partnership to identify novel leadsRichard O Oduor, Kayode K Ojo, Gareth P Williams, et al.
Pageof 149